Frölich M A, Dennis D M, Shuster J A, Melker R J
Department of Anesthesiology, University of Florida Colleges of Medicine and Engineering, Gainesville, Florida, USA.
Br J Anaesth. 2005 Apr;94(4):434-7. doi: 10.1093/bja/aei081. Epub 2005 Jan 28.
The purpose of this study is to test precision and systematic bias of a target controlled infusion (TCI) of propofol in human volunteers at two sedative concentrations.
We studied the 'Diprifusor' model (Marsh Pharmacokinetics and a Graseby 3400 infusion pump) in 18 human volunteers at two sedative target plasma concentrations (0.5 and 1.0 microg ml(-1)). Twenty minutes after infusion start or change and 20 min after discontinuation of the infusion plasma propofol concentrations were measured using liquid chromatography-mass spectroscopy (LC-MS). Plasma propofol concentrations were compared with concentrations predicted by the TCI system. Agreement of those two measures (precision and bias) was determined using regression analysis.
We found little systematic bias but poor precision. When setting the TCI system to deliver a plasma concentration of 1.0 microg ml(-1) one can predict the actual plasma concentration with 95% confidence only within a range of 0.44-1.38 microg ml(-1).
This finding helps to explain differences in responses to propofol sedation; pharmacokinetic variability appears to be an important factor.
本研究旨在测试在两种镇静浓度下,丙泊酚靶控输注(TCI)在人体志愿者中的精度和系统偏差。
我们在18名人体志愿者中,于两种镇静目标血浆浓度(0.5和1.0微克/毫升)下研究了“得普利麻输注器”模型(Marsh药代动力学和Graseby 3400输注泵)。输注开始或改变20分钟后以及输注停止20分钟后,使用液相色谱-质谱联用仪(LC-MS)测量血浆丙泊酚浓度。将血浆丙泊酚浓度与TCI系统预测的浓度进行比较。使用回归分析确定这两种测量方法的一致性(精度和偏差)。
我们发现系统偏差较小,但精度较差。当将TCI系统设置为输送血浆浓度为1.0微克/毫升时,只能在0.44 - 1.38微克/毫升的范围内以95%的置信度预测实际血浆浓度。
这一发现有助于解释丙泊酚镇静反应的差异;药代动力学变异性似乎是一个重要因素。